HLA-B*51 the primary risk in Behçet disease
- PMID: 24876276
- PMCID: PMC4066492
- DOI: 10.1073/pnas.1407307111
HLA-B*51 the primary risk in Behçet disease
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity.Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8867-72. doi: 10.1073/pnas.1406575111. Epub 2014 May 12. Proc Natl Acad Sci U S A. 2014. PMID: 24821759 Free PMC article.
References
-
- Hatemi G, Yazici Y, Yazici H. Behçet’s syndrome. Rheum Dis Clin North Am. 2013;39(2):245–261. - PubMed
-
- Ohno S, et al. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100(9):1455–1458. - PubMed
-
- Mizuki N, et al. Localization of the pathogenic gene of Behçet’s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41(12):3702–3708. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
